期刊文献+

声学定量技术对ARB与ACEI在高血压病治疗中单用与联用优势的评价 被引量:2

Angiotensin receptor blockers and angiotensin converting enzyme inhibitors in treatment of essential hypertension:an evaluation of advantages of single use vs.combined use by acoustics quantity technology
下载PDF
导出
摘要 目的应用超声心动图声学定量技术评价血管紧张素Ⅱ受体拮抗剂(ARB)与血管紧张素Ⅱ转换酶抑制剂(ACEI)在原发性高血压病治疗中单独用药与联合用药的疗效。方法随机选择150例1~3级原发性高血压病患者分为ARB组、ACEI组及ARB-ACEI联合用药组,每组50例,ARB组应用缬沙坦80mg/d、ACEI组应用雅施达4mg/d、ARB-ACEI联合用药组应用缬沙坦80mg/d及雅施达4mg/d口服治疗,3组疗程均为12个月。观察治疗前、治疗后患者血压及症状体征的变化情况、声学定量技术评价心脏形态学、室壁运动状态及心脏整体功能变化情况。结果 (1)3组用药方式均在治疗2w后血压开始下降,5w后趋于平稳。(2)3组受检者的心脏形态学参数在治疗12个月后均明显降低(P<0.01)并趋于稳定,左室壁运动状态及心脏整体功能均随之明显改善(P<0.01)。(3)3组用药方式降压作用均较为明显,但联合用药作用稍优于单独用药(P<0.05),ACEI组在逆转左室重构的疗效较ARB稍优(P<0.05)。结论 (1)ARB及ACEI均能有效逆转原发性高血压病所导致的左室重构,明显改善心脏整体功能,1级及2级高血压可视情况选用单药治疗,而3级高血压可采用联合用药治疗。(2)声学定量技术能够全面、客观地评价心脏结构、室壁运动状态及心脏整体功能情况。 Objective To assess the therapeutic effects of single use and combined use of angiotensin receptor blocker (ARB) and angiotensin converting enzyme inhibitor(ACEI) on essential hypertension by acoustics quantity technology.Methods 150 cases of grade 1-3 essential hypertension were randomly divided into three groups(ns=50):single ARB treatment group(ARB group),single ACEI treatment group(ACEI group) and ARB combined with ACEI treatment group(ARB-ACEI group).ARB group took valsartan of 80 mg/d,ACEI group took perindopril of 4 mg/d and ARB-ACEI group took above two drugs at the same dosage for 12 months.Before and after 12 months of treatment,the blood pressure,symptoms and physical signs of all subjects were observed.The changes of cardinal morphology,wall motion and heart allomeric function were measured by acoustics quantity technology.Results (1) The blood pressure of subjects in three groups decreased gradually after 2 w of treatment,and it appeared a steady tendency after 5 w.(2)The parameters of the cardiac morphology in three groups decreased obviously and became steady after 12 months of treatment (P〈0.01),and left ventricular wall motion as well as heart allomeric function were improved ( P〈0.01 ).(3)All of three therapeutic regimens had remarkable antihypertensive effects,but the combined treatment showed a little better effect than either single drug treatment (P〈0.05 ).ACEI group were better in reversing left ventricular remodeling than ARB group (P〈0.05).Conclusion (1)Both ARB and ACEI can reverse left ventricular remodeling and improve heart allomeric function effectively.Single ARB or ACEI can be used to treat the patients with grade 1-2 essential hypertension according to their conditions,but those with grade 3 essential hypertension should be treated with the combination of ARB and ACEI.(2)Acoustics quantity technology can evaluate cardiac structures,wall motion and heart allomeric function overall and objectively in patients with essential hypertension.
出处 《西南国防医药》 CAS 2010年第11期1164-1168,共5页 Medical Journal of National Defending Forces in Southwest China
基金 四川省卫生厅科学研究基金资助项目(040077)
关键词 声学定量 血管紧张素Ⅱ受体拮抗剂 血管紧张素Ⅱ转换酶抑制剂 高血压 acoustics quantity; angiotensin Ⅱ receptor blocker; angiotensin Ⅱ converting enzyme inhibitor; hypertension;
  • 相关文献

参考文献11

二级参考文献26

  • 1马虹.(8)血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体拮抗剂在心力衰竭治疗中的作用[J].中国循环杂志,2006,21(3):165-167. 被引量:10
  • 2陈长生,徐勇勇,曹秀堂.不等距重复观测数据组间比较的正交回归模型[J].中国卫生统计,1996,13(3):1-5. 被引量:9
  • 3Balci B,Yilmaz O. Influence of left ventricular geometry on regional systolic and diastolic function in patients with essential hypertension. Scand Cardiovasc J, 2002,36 : 292-296.
  • 4Miller JT,O'Rourke RA,Crawford MH. Left atrial enlargement: an early sign of hypertensive heart disease. Am Heart J, 1988, 116: 1048-1051.
  • 5Devereux RB,Alonso DR, Lutas EM. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy finding. Am J Cardiol, 1986,57 : 450-458.
  • 6Li L,Shigematsu Y, Hamada M, et al. Relative wall thickness is an independent predictor of left ventricular systolic and diastolic dysfunctions in essential hypertension. Hypertens Res, 2001,24: 493-499.
  • 7Ganau A, Devereux RB, Roman M J, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol,1992,19:1550-1558.
  • 8H urlburt H M, Aurigemma GP, Gaasch WH, et al. Direct ultrasound measurement of the 3 principal components of left ventricular regional systolic strain. J Am Coil Cardiol, 2006,47 : 116A.
  • 9Nakai H,Takeuchi M, Nishikage T, et al. Effect of aging on twistdisplacement loop by 2-dimensional speckle tracking imaging. J Am Soc Echocardiogr, 2006,19 : 880-885.
  • 10Kim HK, Sohn DW, Lee SE, et al. Assessment of left ventricular rotation and torsion with two-dimensional speckle tracking echocardiography. J Am Soc Echocardiogr, 2007,20 : 45-53.

共引文献71

同被引文献34

  • 1Giles T D, Alessi T, Purkayastha D, et al. Comparative effi-cacy of aliskiren/valsartan vs valsartan in nocturnal dipper andnondipper hypertensive patients: a pooled analysis[J]. J ClinHypertens (Greenwich), 2012,14(5) : 299.
  • 2Walash M I, Belal F F, El - Enany N M, et al. Synchronousfluorescence spectrofluorimetric method for the simultaneousdetermination of metoprolol and felodipine in combined phar-maceutical preparation[J]. Chem Cent J, 2011,5(1) : 70.
  • 3Parati G, Faini A, Valentini M. Blood pressure variability:its measurement and significance in hypertension[J]. Curr Hy-pertens Rep, 2006, 8(3): 199.
  • 4VOLPE M,SAVOIA C, De PAOLIS P,et al. The renin-angio- tensin system as a risk factor and therapeutic target for cardio- vascular and renal disease [ J ]. J Am Soc Nephrol, 2002,13: S173-S178.
  • 5OMBONI S, MALACCO E, PARATI G. Zofenopril plus hydro- chlorothiazide fixed combination in the treatment of hyper-tension and associated clinical conditions [ J ]. Cardiovascular Th- erapeutics ,2009,27 (4) :275-288.
  • 6JOANNIDES R, BELLIEN J,THURLURE C, et al. Fixed com- bination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after a- cute administration[J]. American Journal of Hypertension,2008, 21 (6) ;679-684.
  • 7KELLY A S, GONZALEZ-CAMPOY J M, RUDSER K D, et al. Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension [ J ]. Journal of Clinical Hypertension,2012,14(2) :85-91.
  • 8JAMERSON K, WEBER M A, BAKRIS G L, et al. Benazepril plus amlodipine or hydroehlorothiazide for hypertension in high- risk patients[J]. N Engl J Med,2008,359(23):2417-428.
  • 9MANN J F, SCHMIEDER R E, MCQUEEN M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk ( the ONTARGET study) : a multicentre, random- ised,double-blind,controlled trial[J], l.ancet,2008,372(9638) : 547-553.
  • 10McMURRAY J, SOLOMON S, PIEPER K, et al. The Effect of valsartan, captopril, or both on atherosclerotic events after a- cute myocardial infarctionan analysis of the valsartan in acute myocardial infarction trial (VALIANT) [ J ]. Journal of the A- merican College of Cardiology, 2006,47 (4) : 726- 733.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部